Intouch Solutions
JULY 10, 2020
We may need mindfulness now more than ever. Find out how Intouch helps employees get through stressful times by providing tips on mindfulness and so much more. The post Mindfulness: How Meditation Can Help in Uncertain Times appeared first on Intouch Solutions.
Druggist
JULY 8, 2020
I today’s post I will discuss the best iron supplement in the UK. There is an endless number of iron and multivitamin supplements available in supermarkets and pharmacies. Patients who are deficient of iron and require to take supplements can buy the best iron products from a pharmacy. The best of all, iron supplements available in UK pharmacies are cheap and effective.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
JULY 7, 2020
Great digital should be personal. As the Covid-19 environment continues to cause brands to shift more heavily toward digital and increase their non-physical tactics, it is important to remember this. We must work hard to keep these interactions personal. Personalization of content, experiences, and support services is already a mainstay of ecommerce and retail.
Eye on FDA
JULY 8, 2020
I don’t usually publish the scheduling of an AdComm with a blog posting. But this one merits one. With fewer than the usual minimum of fifteen days’ notice, FDA has scheduled an FDA Advisory Committee meeting of the Cardiovascular and Renal Drugs Advisory Committee to discuss a new drug application (NDA) for terlipressin, lyophilized power for solution for injection for the proposed indication of the treatment of hepatorenal syndrome.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Intouch Solutions
JULY 7, 2020
In early March 2020, the violator - a simple badge, or on-page announcement - began to appear on websites. COVID-19 violators are now ubiquitous. Find out why this should matter to pharma marketers. The post COVID-19 and Its Impact on Healthcare Website Design appeared first on Intouch Solutions.
Druggist
JULY 5, 2020
Blocked nose in babies is a common occurrence. Thankfully there are many non-medicated products, which can be used to help with stuffy noses. Most ‘baby’ products which are available for the management of congestion can be used in newborn babies with few the exception of some vapour rubs. Popular product available this review can be broadly divided into: Saline nasal sprays and drops Nasal aspirator (manual and electric) Vapour rubs and vapour oils Electric plugs (Calpol Vapour Plug)
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Eye on FDA
JULY 7, 2020
At mid-year, it has been a custom here at Eye on FDA to look back at a few categories of activity by FDA at the first half of the year and discern what it tells us about future directions. This year the unprecedented circumstances presented by the COVID-19 pandemic make it particularly interesting this year. A good place to start is with regulatory enforcement of the Office of Prescription Drug Promotion (#OPDP).
Clinical Trial Gurus
JULY 10, 2020
Although clinicaltrials.gov is intended for research patients, the reality is that research sites may be the only ones using the website. Job seekers should also consider using the website as a way to network and potentially land a new job. Although the response rate is very low, the cost of using the website is also low and the reward can be very high.
Forte Research Systems®
JULY 9, 2020
Maintaining complete, compliant documentation during a trial can be challenging. ISFs help ensure ICH E6 (R2) section 8 are met by checking the content of a variety of documents.
ECRG Media's Clinical Research Podcast
JULY 8, 2020
What is Source Document Review (SDR)? Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education Send in a voic
Drug Channels
JULY 8, 2020
This week (Monday through Thursday), I’m rerunning some popular posts. Click here to see the original post and comments from April 2020. The U.S. economy is in a medically-induced coma. Unemployment is soaring. Companies are teetering on the brink of bankruptcy. It is unclear when our lives will return to their pre-pandemic state. One thing seems apparent: As people lose jobs and health insurance, Medicaid enrollment will jump, perhaps by as much as 20% to 30%.
Triage Cancer
JULY 8, 2020
Academic research has even given a name to the financial burden of cancer, referred to as financial toxicity. Given that some form of financial burden often accompanies a cancer diagnosis, exacerbated now by the pandemic, retirement accounts may serve as vital financial lifelines for individuals and families impacted by cancer. Although designed for retirement and use after the age of 59 1/2, IRAs and employer retirement plans may in fact be accessed early.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
ECRG Media's Clinical Research Podcast
JULY 8, 2020
What is Source Document Review (SDR)? Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education.
Drug Channels
JULY 7, 2020
This week (Monday through Thursday), I’m rerunning some popular posts. Click here to see the original post and comments from February 2020. Pharmacy-related price concessions in Medicare Part D—known as pharmacy DIR fees --have grown faster than most people realize. We estimate that these payments reached $9.1 billion in 2019. This figure indicates that about 18% of total Medicare Part D rebates are now paid by pharmacies, not manufacturers.
Clinical Trial Gurus
JULY 8, 2020
A hospital CEO talks about his views on the impact of COVID-19 during the early phases of the pandemic. One of the takeaways from this video is that training even if it is done from home, can prepare anyone for unforeseeable setbacks in the market. Throughout the video several references are made to major events in the past that made an impact on the overall job market.
Forte Research Systems®
JULY 7, 2020
The COVID-19 pandemic forced an era of research quickly adjusting to continue high-quality research. Most adaptions, however, have positioned research to be more patient centric, streamlined, and remote.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Syntegon Technology Pharma Blog
JULY 7, 2020
My Local Study
JULY 6, 2020
COVID-19 has put a damper on many things. Businesses have had to let people go because they cannot sustain revenues, and we are on the choppy ride of the second wave of the virus infection. Most schools are out for the summer, and many are left wondering when it will end, and what they can. Read more Summer, Volunteering, and COVID19. The post Summer, Volunteering, and COVID19 appeared first on MyLocalStudy.com.
Clinical Trial Gurus
JULY 6, 2020
Virtual trials have quickly become an integral component of the research industry. The guest in the video explains that some of the benefits that virtual trials can rely on is that they are flexible and can be adapted to meet the needs of any given protocol. Additionally, virtual trials also serve as a convenient method of participating clinical trials for patients.
Drug Channels
JULY 10, 2020
Today’s guest post comes from Rick Fry, Senior Vice President of Commercial Solutions and Jason Zemcik, Senior Director of Product Management at TrialCard. Rick and Jason outline their view of the crucial issues in the new proposed rule from Centers for Medicare and Medicaid Services (CMS) regarding copay accumulator adjustment programs. They preview the public comments that TrialCard expects to submit to CMS.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Checkers
JULY 10, 2020
I have written extensively about how the pharmaceutical industry and its allies deceive the public by conflating the issue of counterfeit drugs with safe, more affordable prescription medicines that Americans purchase online and import for personal use. One of the industry’s main tactics is to make the counterfeit drug problem look as big as possible.
Pharma in Brief
JULY 7, 2020
The Patented Medicine Prices Review Board ( PMPRB or Board ) has found that a patent can pertain to a medicine based on clinical similarities to the invention—even if the patent does not actually encompass the medicine. Background. This case concerns Canadian Patent No. 2,478,237 (the 237 Patent ), which relates to the use of adapalene to treat dermatological disorders.
Drug Channels
JULY 6, 2020
This week (Monday through Thursday), I’m rerunning some popular posts. Click here to see the original post and comments from March 2020. Next week, Drug Channels Institute will release our 2020 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. It’s the 11th edition of our popular and comprehensive examination of the entire drug pricing, reimbursement, and dispensing system.
Drug Channels
JULY 6, 2020
This week (Monday through Thursday), I’m rerunning some popular posts. Click here to see the original post and comments from March 2020. Next week, Drug Channels Institute will release our 2020 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. It’s the 11th edition of our popular and comprehensive examination of the entire drug pricing, reimbursement, and dispensing system.
Expert insights. Personalized for you.
81 
Let's personalize your content